Rabilite-LS combines Rabeprazole and Levosulpiride to treat hyperacidity, dyspepsia, and gastro-oesophageal reflux disease.
Route of Administration
Oral
Composition
Each capsule contains:
- Rabeprazole Sodium (as enteric coated pellets) I.P. 20 mg
- Levosulpiride (as sustained release pellets) 75 mg
- Excipients q.s.
Indications
Used for hyperacidity, dyspepsia, and gastro-oesophageal reflux disease (GERD).
Storage
Store protected from light and moisture at a temperature not exceeding 25°C.
Precautions
Use with caution in patients with liver impairment, a history of epilepsy, or elevated prolactin levels. Not recommended for children below 14 years of age. Breastfeeding women should consult a physician before use.
Presentation
10x10 capsules in a unit carton.
